BioSpace News Archive

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, and the Medicines Patent Pool (MPP) today announced the signing of a new voluntary licensing agreement for patents relating to cabotegravir long-acting (LA) for HIV pre-exposure prophylaxis (PrEP) to help enable access in least developed, low-income, lower middle-income and Sub-Saharan African countries.

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) (“Kiora” or the “Company”) has been granted a U.S. patent covering hydrogel-based sustained release platforms, inclusive of KIO-201, which enable controlled release of antibiotics for the treatment of ocular diseases.

The latest market analysis report published by Reports and Data, titled ‘Global Chronic Fatigue Market – Forecast to 2030,’ thoroughly examines the Chronic Fatigue industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Exocrine Pancreatic Insufficiency Market – Forecast to 2030,’ thoroughly examines the Exocrine Pancreatic Insufficiency industry to provide essential data & information for the targeted readers.

The appointment of four new members to the Praxis Spinal Cord Institute board of directors is bringing welcome experience in finance, governance, community, and health care to the board.

Inventiva, a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with non-alcoholic steatohepatitis and other diseases with significant unmet medical needs, reported its cash position as of June 30, 2022, and its revenues for the first half of 2022.

Vaxart, Inc. announced it will provide a business update and report financial results for the second quarter ended June 30, 2022 after the market close on Monday, August 8, 2022.

AVEO Oncology, a commercial stage, oncology-focused biopharmaceutical company, announced that it will report second quarter 2022 financial results on Thursday, August 4, 2022.

Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in vivo to treat patients with solid and hematologic malignancies, announced new data at the 2022 iPSC Manufacturing Summit held in Boston, Mass.

Eargo, Inc., a medical device company on a mission to improve hearing health, announced it will release financial results for the second quarter 2022 after market close on August 8, 2022.